4 results on '"Velentzis, Louiza S"'
Search Results
2. Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know
- Author
-
Velentzis, Louiza S., Woodside, Jayne V., Cantwell, Marie M., Leathem, Anthony J., and Keshtgar, Mohammed R.
- Subjects
- *
PHYTOESTROGENS , *LIGNANS , *BREAST cancer , *CANCER relapse - Abstract
Abstract: Oestrogen is an important determinant of breast cancer risk. Oestrogen-mimicking plant compounds called phytoestrogens can bind to oestrogen receptors and exert weak oestrogenic effects. Despite this activity, epidemiological studies suggest that the incidence of breast cancer is lower in countries where the intake of phytoestrogens is high, implying that these compounds may reduce breast cancer risk, and possibly have an impact on survival. Isoflavones and lignans are the most common phytoestrogens in the diet. In this article, we present findings from human observational and intervention studies related to both isoflavone and lignan exposure and breast cancer risk and survival. In addition, the clinical implications of these findings are examined in the light of a growing dietary supplement market. An increasing number of breast cancer patients seek to take supplements together with their standard treatment in the hope that these will either prevent recurrence or treat their menopausal symptoms. Observational studies suggest a protective effect of isoflavones on breast cancer risk and the case may be similar for increasing lignan consumption although evidence so far is inconsistent. In contrast, short-term intervention studies suggest a possible stimulatory effect on breast tissue raising concerns of possible adverse effects in breast cancer patients. However, owing to the dearth of human studies investigating effects on breast cancer recurrence and survival the role of phytoestrogens remains unclear. So far, not enough clear evidence exists on which to base guidelines for clinical use, although raising patient awareness of the uncertain effect of phytoestrogens is recommended. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
3. Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study.
- Author
-
Canfell, Karen, Egger, Sam, Velentzis, Louiza S., Brown, Jessica Darlington, O’Connell, Dianne L., Banks, Emily, and Sitas, Freddy
- Subjects
- *
HUMAN papillomavirus vaccines , *YOUNG women , *PUBLIC health , *SEXUALLY transmitted diseases , *SOCIAL status , *HEALTH - Abstract
Background Australia commenced a publically-funded, National Human Papillomavirus (HPV) Vaccination Program in 2007 with a two year catch-up phase for females aged 12–26 years. Objective To identify the factors associated with the uptake of the HPV vaccine (which has a recommended 3-dose schedule in Australia) by young adult women vaccinated by general practitioners and community-based programs within the catch-up phase. Methods 1139 women who were eligible to receive the free HPV vaccine during the catch-up period were recruited in 2008–2009 (age 20–29 years at recruitment), in New South Wales, after having a normal (negative) cervical smear result recorded on the NSW Pap Test Register. Participants completed a self-administered questionnaire providing information on vaccination status, and sociodemographic and other factors. Results Overall, 880 (77%) women reported receiving ≥1 dose of the vaccine and 777 women (68%) reported receiving ≥2 doses. In multivariable analysis (adjusting for the period for which each woman was eligible for free HPV vaccination), uptake of ≥1 dose of the vaccine was significantly associated with being born in Australia ( p < 0.01), being single ( p = 0.02), being nulliparous ( p < 0.01), living in a higher socioeconomic status area ( p -trend = 0.03), living in more remote areas ( p = 0.03), drinking alcohol ( p < 0.01) and using hormonal contraceptives ( p < 0.01). Although vaccinated women were more likely to have fewer sexual partners than unvaccinated women ( p -trend = 0.02), they were also more likely to report a prior sexually transmitted infection (STI) ( p = 0.03). Similar factors were associated with receiving ≥2 doses. Conclusions In this group, women living in higher socioeconomic status areas were more likely to be vaccinated against HPV in the catch-up phase of the national program. Although vaccinated women tended to have fewer sexual partners, they also reported prior STIs, which may be a marker of increased risk of prior exposure to HPV. The findings of this study reinforce the continuing need to prioritise equitable delivery of vaccination to various population subgroups. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
4. The DietCompLyf study: A prospective cohort study of breast cancer survival and phytoestrogen consumption.
- Author
-
Swann, Ruth, Perkins, Katherine A., Velentzis, Louiza S., Ciria, Cristian, Dutton, Susan J., Mulligan, Angela A., Woodside, Jayne V., Cantwell, Marie M., Leathem, Anthony J., Robertson, Claire E., and Dwek, Miriam V.
- Subjects
- *
BREAST cancer treatment , *PHYTOESTROGENS , *LIFESTYLES & health , *CANCER relapse , *QUALITY of life , *ISOFLAVONES - Abstract
Abstract: DietCompLyf is a multi-centre prospective study designed to investigate associations between phytoestrogens – naturally occurring plant compounds with oestrogenic properties – and other diet and lifestyle factors with breast cancer recurrence and survival. 3159 women with grades I–III breast cancer were recruited 9–15 months post-diagnosis from 56 UK hospitals. Detailed information on clinico-pathological, diet, lifestyle and quality of life is collected annually up to 5 years. Biological samples have also been collected as a resource for subsequent evaluation. The characteristics of the patients and associations between pre-diagnosis intake of phytoestrogens (isoflavones and lignans; assessed using the EPIC-Norfolk UK 130 question food frequency questionnaire) and breast cancer (i) risk factors and (ii) prognostic factors are described for 1797 women who had complete data for all covariates and phytoestrogens of interest. Isoflavone intakes were higher in the patients who were younger at diagnosis, in the non-smokers, those who had breast-fed and those who took supplements. Lignan intakes were higher in patients with a higher age at diagnosis, in ex-smokers, those who had breast-fed, who took supplements, had a lower BMI at diagnosis, lower age at menarche and were nulliparous. No significant associations between pre-diagnosis phytoestrogen intake and factors associated with improved breast cancer prognosis were observed. The potential for further exploration of the relationship between phytoestrogens and breast cancer recurrence and survival, and for the establishment of evidence to improve dietary and lifestyle advice offered to patients following breast cancer diagnosis using DietCompLyf data is discussed. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.